What’s Next? Five Things To Look Out For In January
Humira’s US LOE Finally Arrives And Key Appointments Shape Industry
Executive Summary
The biggest loss of exclusivity in pharmaceutical history is set to steal headlines in the first month of 2023, as Teva begins a new year with a new CEO.